Study: What is the Role of Fibrocytes and Endothelial Progenitor Cells in Lung Sarcoidosis?
source: pixabay.com

Study: What is the Role of Fibrocytes and Endothelial Progenitor Cells in Lung Sarcoidosis?

A study published in BMC Pulmonary Medicine focuses on the role of endothelial progenitor cells and fibrocytes in lung sarcoidosis. They specifically investigated how these cells, along with CD34 + cells, spurred…

Continue Reading Study: What is the Role of Fibrocytes and Endothelial Progenitor Cells in Lung Sarcoidosis?
Rare Classroom: Sarcoidosis
source: shutterstock

Rare Classroom: Sarcoidosis

Welcome to the Rare Classroom, a new series from Patient Worthy. Rare Classroom is designed for the curious reader who wants to get informed on some of the rarest, most…

Continue Reading Rare Classroom: Sarcoidosis

Study: The Relationship Between Obesity, Lung Diseases, and Pulmonary Hypertension in Transplant Patients

The United States is coping with an obesity epidemic. It is therefore critical to understand the distribution of body fat and its effect on treatment. A recent article in Healio…

Continue Reading Study: The Relationship Between Obesity, Lung Diseases, and Pulmonary Hypertension in Transplant Patients
Phase 2a Trial of Experimental Pulmonary Arterial Hypertension Drug Begins
source: pixabay.com

Phase 2a Trial of Experimental Pulmonary Arterial Hypertension Drug Begins

According to a story from BioSpace, the biopharmaceutical company Altavant Sciences has recently announced that the first patient has been dosed in a phase 2a proof of concept trial. This…

Continue Reading Phase 2a Trial of Experimental Pulmonary Arterial Hypertension Drug Begins

87 Businesses Across Two Countries Displayed a Purple Light for Sarcoidosis Awareness Last Month

Sarcoidosis Sarcoidosis is a rare inflammatory condition that causes granulomas to buildup within the organs. These can cause permanent organ damage. While the condition can affect various organs, and presents…

Continue Reading 87 Businesses Across Two Countries Displayed a Purple Light for Sarcoidosis Awareness Last Month
Pulmonary Hypertension Drugs are Effective for Some Sarcoidosis Patients, Study Says
oracast / Pixabay

Pulmonary Hypertension Drugs are Effective for Some Sarcoidosis Patients, Study Says

According to a story from Pulmonary Hypertension News, many patients with the rare disease sarcoidosis frequently experience lung complications. Included in these complications is pulmonary hypertension, a condition of elevated…

Continue Reading Pulmonary Hypertension Drugs are Effective for Some Sarcoidosis Patients, Study Says
Scientists Hopeful About Potential Sarcoidosis Treatment
For most people, sarcoidosis is not fatal, but beware of pulmonary hypertension

Scientists Hopeful About Potential Sarcoidosis Treatment

According to the Shillong Times, a study published in the New England Journal of Medicine has reported intriguing results when treating sarcoidosis with an already-approved rheumatoid arthritis medication. What is…

Continue Reading Scientists Hopeful About Potential Sarcoidosis Treatment
Company Plans Clinical Trial of Autonomic Regulation Therapy to Treat Heart Failure
geralt / Pixabay

Company Plans Clinical Trial of Autonomic Regulation Therapy to Treat Heart Failure

According to a story from Compelo, the medical technology company LivaNova is kicking off an international trial that will assess the use of autonomic regulation therapy as a treatment for…

Continue Reading Company Plans Clinical Trial of Autonomic Regulation Therapy to Treat Heart Failure
Risk of Heart Failure in Older Women Can be Reduced With Exercise, Study Says
Ben_Kerckx / Pixabay

Risk of Heart Failure in Older Women Can be Reduced With Exercise, Study Says

According to a story from Reuters, a recent study found that mild exercise, such as walking, can significantly reduce the risk of heart failure in older, postmenopausal women. This large…

Continue Reading Risk of Heart Failure in Older Women Can be Reduced With Exercise, Study Says
A Study Highlights the Benefit of a New Treatment for COPD. Could it Work in Rare Lung Diseases as Well?
source: pixabay.com

A Study Highlights the Benefit of a New Treatment for COPD. Could it Work in Rare Lung Diseases as Well?

According to a story from bioportfolio.com, a recent study has demonstrated the effectiveness of Trelegy Ellipta, a unique three component combination treatment, in reducing the effects of chronic obstructive pulmonary…

Continue Reading A Study Highlights the Benefit of a New Treatment for COPD. Could it Work in Rare Lung Diseases as Well?
The FDA is Beginning to Accept New Endpoints and “Real World” Data in Clinical Trials
vitalworks / Pixabay

The FDA is Beginning to Accept New Endpoints and “Real World” Data in Clinical Trials

According to a story from Charcot-Marie-Tooth Disease News, the U.S. Food and Drug Administration (FDA), under the leadership of commissioner Scott Gottlieb, has begun to change clinical trials by accepting…

Continue Reading The FDA is Beginning to Accept New Endpoints and “Real World” Data in Clinical Trials